Mathurin, Philippe

Alcoholic liver disease

Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers

Alcohol Consumption and Health EffectsLiver Disease Diagnosis and Treatment

Cited by 1,271

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

Yau, T., Park, J.-W., Finn, R. S., Cheng, A.-L., Mathurin, P., Edeline, J., Kudo, M., Harding, J. J., Merle, P., Rosmorduc, O., et al. (2022) · The Lancet Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 1,106

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 1,035

Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients

Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology

Bariatric Surgery and OutcomesLiver Disease Diagnosis and Treatment

Cited by 762

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Corpechot, C., Chazouillères, O., Rousseau, A., Le Gruyer, A., Habersetzer, F., Mathurin, P., Goria, O., Potier, P., Minello, A., Silvain, C., et al. (2018) · New England Journal of Medicine

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 642

Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis

Lassailly, G., Caiazzo, R., Ntandja-Wandji, L.-C., Gnemmi, V., Baud, G., Verkindt, H., Ningarhari, M., Louvet, A., Leteurtre, E., Raverdy, V., et al. (2020) · Gastroenterology

Liver Disease Diagnosis and TreatmentBariatric Surgery and Outcomes

Cited by 622

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors

Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology

Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes

Cited by 553

Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites

Bureau, C., Thabut, D., Oberti, F., Dharancy, S., Carbonell, N., Bouvier, A., Mathurin, P., Otal, P., Cabarrou, P., Péron, J. M., et al. (2017) · Gastroenterology

Liver Disease and TransplantationOrgan Transplantation Techniques and Outcomes

Cited by 452

Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review

Singal, A. K., & Mathurin, P. (2021) · JAMA

Alcohol Consumption and Health EffectsLiver Disease and Transplantation

Cited by 398

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

Ratziu, V., de Ledinghen, V., Oberti, F., Mathurin, P., Wartelle-Bladou, C., Renou, C., Sogni, P., Maynard, M., Larrey, D., Serfaty, L., et al. (2011) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 338

Trends in the management and burden of alcoholic liver disease

Mathurin, P., & Bataller, R. (2015) · Journal of Hepatology

Alcohol Consumption and Health EffectsLiver Disease and Transplantation

Cited by 288

Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease: A 5-Year Controlled Longitudinal Study

Caiazzo, R., Lassailly, G., Leteurtre, E., Baud, G., Verkindt, H., Raverdy, V., Buob, D., Pigeyre, M., Mathurin, P., & Pattou, F. (2014) · Annals of Surgery

Bariatric Surgery and OutcomesLiver Disease Diagnosis and Treatment

Cited by 226

Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis

Sanyal, A. J., Ratziu, V., Loomba, R., Anstee, Q. M., Kowdley, K. V., Rinella, M. E., Sheikh, M. Y., Trotter, J. F., Knapple, W., Lawitz, E. J., et al. (2023) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 137

Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis

Liu, M., Cao, S., He, L., Gao, J., Arab, J. P., Cui, H., Xuan, W., Gao, Y., Sehrawat, T. S., Hamdan, F. H., et al. (2021) · Nature Communications

Alcohol Consumption and Health EffectsGenomics and Chromatin Dynamics

Cited by 120

Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021

Danpanichkul, P., Díaz, L. A., Suparan, K., Tothanarungroj, P., Sirimangklanurak, S., Auttapracha, T., Blaney, H. L., Sukphutanan, B., Pang, Y., Kongarin, S., et al. (2025) · Clinical and Molecular Hepatology

Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes

Cited by 85

Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis

Bou Saleh, M., Louvet, A., Ntandja-Wandji, L. C., Boleslawski, E., Gnemmi, V., Lassailly, G., Truant, S., Maggiotto, F., Ningarhari, M., Artru, F., et al. (2021) · Journal of Hepatology

Hippo pathway signaling and YAP/TAZLiver physiology and pathology

Cited by 83

Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis

Taı̈eb, J., Delarche, C., Paradis, V., Mathurin, P., Grenier, A., Crestani, B., Dehoux, M., Thabut, D., Gougerot-Pocidalo, M.-A., Poynard, T., et al. (2002) · Journal of Hepatology

Liver physiology and pathologyAlcohol Consumption and Health Effects

Cited by 73

Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis

Martin-Mateos, R., De Assuncao, T. M., Arab, J. P., Jalan-Sakrikar, N., Yaqoob, U., Greuter, T., Verma, V. K., Mathison, A. J., Cao, S., Lomberk, G., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 73

Acute Liver Injury With Therapeutic Doses of Acetaminophen: A Prospective Study

Louvet, A., Ntandja Wandji, L. C., Lemaître, E., Khaldi, M., Lafforgue, C., Artru, F., Quesnel, B., Lassailly, G., Dharancy, S., & Mathurin, P. (2021) · Hepatology

Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments

Cited by 63

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

Corpechot, C., Chazouillères, O., Rousseau, A., Guyader, D., Habersetzer, F., Mathurin, P., Goria, O., Potier, P., Minello, A., Silvain, C., et al. (2017) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 45

Faecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis

Kreimeyer, H., Gonzalez, C. G., Fondevila, M. F., Hsu, C. L., Hartmann, P., Zhang, X., Stärkel, P., Bosques-Padilla, F., Verna, E. C., Abraldes, J. G., et al. (2025) · Gut

Alcohol Consumption and Health EffectsNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 12